2016
DOI: 10.3109/14756366.2016.1170014
|View full text |Cite
|
Sign up to set email alerts
|

The synthesis of some β-lactams and investigation of their metal-chelating activity, carbonic anhydrase and acetylcholinesterase inhibition profiles

Abstract: b-Lactam antibiotics are a broad class of antibiotics, consisting of all antibiotic agents that contain a b-lactam ring in their molecular structures. Synthesis of b-lactam analogs, which are containing dichloride atoms and N-methyl, N-aromatic rings, was achieved by Schiff bases and dichloroketene compounds. All the synthesized imines and b-lactam analogs were tested against two physiologically relevant carbonic anhydrase isozymes (hCA I and II) and acetylcholinesterase (AChE). They demponstrated effective in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
72
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 105 publications
(72 citation statements)
references
References 107 publications
0
72
0
Order By: Relevance
“…[54] In this study, we obtained the effects of novel amides of 1,1-bis-(carboxymethylthio)-1arylethanes derivatives (1-11) against hCA I, hCA II, AChE, and BChE enzymes. [55] In addition, hCA II is the most TA B L E 1 The enzyme inhibition results of novel amides of 1,1-bis-(carboxymethylthio)-1-arylethanes (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11) extensively studied and characterized of the hCA isoforms. hCA II is often associated with several diseases such as glaucoma, osteoporosis, and renal tubular acidosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[54] In this study, we obtained the effects of novel amides of 1,1-bis-(carboxymethylthio)-1arylethanes derivatives (1-11) against hCA I, hCA II, AChE, and BChE enzymes. [55] In addition, hCA II is the most TA B L E 1 The enzyme inhibition results of novel amides of 1,1-bis-(carboxymethylthio)-1-arylethanes (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11) extensively studied and characterized of the hCA isoforms. hCA II is often associated with several diseases such as glaucoma, osteoporosis, and renal tubular acidosis.…”
Section: Discussionmentioning
confidence: 99%
“…[25][26][27][28][29] In this study, we have performed the synthesis of well-defined novel amide of 1,1-bis-(carboxymethylthio)-1-arylethanes derivatives (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11). [25][26][27][28][29] In this study, we have performed the synthesis of well-defined novel amide of 1,1-bis-(carboxymethylthio)-1-arylethanes derivatives (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11).…”
Section: Introductionmentioning
confidence: 99%
“…It is well known that β-lactams had inhibition properties on hCA I, and II isoenzymes and are used in therapies [52,53]. The inhibition effects of newly synthesized compounds 2a – k were determined for the first time against hCA I, and II.…”
Section: Resultsmentioning
confidence: 99%
“…Also, β-lactam derivative 2g shown the most powerful CA I inhibition effect with a K i value of 0.35 ± 0.105 nM. On the other hand, we found that acetazolamide (AZA), which is used as a clinical CA inhibitor in the treatment of glaucoma, cystinuria, epilepsy, altitude sickness, periodic paralysis, dural ectasia, idiopathic intracranial hypertension, and central sleep apnoea [52], has a K i value of 170.34 ± 2.48 nM (Table 2). The results clearly show that all β-lactam derivatives 2a – k demonstrate more effective hCA inhibitory activity than that of AZA.…”
Section: Resultsmentioning
confidence: 99%
“…Six distinct genetic CA families, the a-, b-, g-, d-, z-and Z-CAs, are known to date, constituting an interesting example of convergent evolution at the molecular level [30][31][32] . Also, to date, 16 different CA isoenzymes are described in various organisms 33,34 .…”
Section: Introductionmentioning
confidence: 99%